Home1795 • TPE
add
Lotus Pharmaceutical Co Ltd
Previous close
$285.50
Day range
$281.00 - $285.50
Year range
$210.50 - $347.00
Market cap
74.78B TWD
Avg Volume
2.32M
P/E ratio
17.09
Dividend yield
1.65%
Primary exchange
TPE
Market news
Financials
Income Statement
Revenue
Net income
(TWD) | Sep 2024info | Y/Y change |
---|---|---|
Revenue | 5.23B | 14.45% |
Operating expense | 1.20B | 3.23% |
Net income | 1.57B | 25.62% |
Net profit margin | 29.90 | 9.77% |
Earnings per share | 5.98 | 25.63% |
EBITDA | 2.41B | 37.95% |
Effective tax rate | 17.54% | — |
Balance Sheet
Total assets
Total liabilities
(TWD) | Sep 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 3.69B | 79.67% |
Total assets | 37.23B | 13.00% |
Total liabilities | 17.02B | 5.27% |
Total equity | 20.22B | — |
Shares outstanding | 265.19M | — |
Price to book | 3.74 | — |
Return on assets | 14.69% | — |
Return on capital | 17.09% | — |
Cash Flow
Net change in cash
(TWD) | Sep 2024info | Y/Y change |
---|---|---|
Net income | 1.57B | 25.62% |
Cash from operations | 1.91B | 40.51% |
Cash from investing | -1.51B | -168.17% |
Cash from financing | 444.77M | 178.21% |
Net change in cash | 831.22M | 186.06% |
Free cash flow | -329.04M | 35.47% |
About
Founded
1966
Website
Employees
1,099